A novel regulation of PD-1 ligands on mesenchymal stromal cells through MMP-mediated proteolytic cleavage

OncoImmunology

Volumn 5, Issue 3, 2016, Pages

  Dezutter Dambuyant, Colette ^a,b,c   Durand, Isabelle ^a,b,c   Alberti, Laurent ^a,b,c   Bendriss Vermare, Nathalie ^a,b,c   Valladeau Guilemond, Jenny ^a,b,c   Duc, Adeline ^a,b,c   Magron, Audrey ^a,b,c   Morel, Anne Pierre ^a,b,c   Sisirak, Vanja ^a,b,c   Rodriguez, Céline ^a,b,c   Cox, David ^a,b,c   Olive, Daniel ^d   Caux, Christophe ^a,b,c  

^a UNIVERSITÉ DE LYON   (France)

^b UNIVERSITÉ LYON 1   (France)

^c CENTRE DE RECHERCHE EN CANCÉROLOGIE DE LYON   (France)

^d AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Apoptosis; fibroblasts; immunosuppression; MMP 13; PD L1; PD L2; PD1

Indexed keywords

5' NUCLEOTIDASE; B7 ANTIGEN; BETA GALACTOSIDASE; CD146 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; CD86 ANTIGEN; COLLAGENASE; COLLAGENASE 3; DISPASE; ENDOGLIN; GELATINASE B; MATRIX METALLOPROTEINASE; PROGRAMMED DEATH 1 LIGAND 1; PROGRAMMED DEATH 1 LIGAND 2; THERMOLYSIN; THY 1 ANTIGEN;

APOPTOSIS; ARTICLE; CARCINOMA; CD3+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL COUNT; CELL INTERACTION; CELL ISOLATION; CELL PROLIFERATION; CHILD; CONTROLLED STUDY; ENZYME ACTIVITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MESENCHYMAL STROMA CELL; MONOCYTE; NORMAL HUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPE; POLYMERASE CHAIN REACTION; PREPUCE; PRESCHOOL CHILD; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; PROTEIN SECRETION; SKIN FIBROBLAST; UPREGULATION;

EID: 84961636927     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.1080/2162402X.2015.1091146     Document Type: Article

References (84)

1. M.E.Bernardo, W.E.Fibbe. Mesenchymal stromal cells: sensors and switchers of inflammation. Cell Stem Cell 2013; 13:392-402; PMID:24094322; http://dx.doi.org/10.1016/j.stem.2013.09.006
2. P.S.Frenette, S.Pinho, D.Lucas, C.Scheiermann. Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine. Annu Rev Immunol 2013; 31:285-316; PMID:23298209; http://dx.doi.org/10.1146/annurev-immunol-032712-095919
3. B.K.Le, D.Mougiakakos. Multipotent mesenchymal stromal cells and the innate immune system. Nat Rev Immunol 2012; 12:383-96; PMID:22531326; http://dx.doi.org/10.1038/nri3209
4. H.Y.Chang, J.T.Chi, S.Dudoit, C.Bondre, M.van de Rijn, D.Botstein, P.O.Brown. Diversity, topographic differentiation, and positional memory in human fibroblasts. Proc Natl Acad Sci U S A 2002; 99:12877-82; PMID:12297622; http://dx.doi.org/10.1073/pnas.162488599
5. M.A.Haniffa, X.N.Wang, U.Holtick, M.Rae, J.D.Isaacs, A.M.Dickinson, C.M.Hilkens, M.P.Collin. Adult human fibroblasts are potent immunoregulatory cells and functionally equivalent to mesenchymal stem cells. J Immunol 2007; 179:1595-604; PMID:17641026; http://dx.doi.org/10.4049/jimmunol.179.3.1595
6. S.Cappellesso-Fleury, B.Puissant-Lubrano, P.A.Apoil, M.Titeux, P.Winterton, L.Casteilla, P.Bourin, A.Blancher. Human fibroblasts share immunosuppressive properties with bone marrow mesenchymal stem cells. J Clin Immunol 2010; 30:607-19; PMID:20405178; http://dx.doi.org/10.1007/s10875-010-9415-4
7. S.Jones, N.Horwood, A.Cope, F.Dazzi. The antiproliferative effect of mesenchymal stem cells is a fundamental property shared by all stromal cells. J Immunol 2007; 179:2824-31; PMID:17709496; http://dx.doi.org/10.4049/jimmunol.179.5.2824
8. K.Rasanen, A.Vaheri. Activation of fibroblasts in cancer stroma. Exp Cell Res 2010; 316:2713-22; PMID:20451516; http://dx.doi.org/10.1016/j.yexcr.2010.04.032
9. C.D.Buckley, D.Pilling, J.M.Lord, A.N.Akbar, D.Scheel-Toellner, M.Salmon. Fibroblasts regulate the switch from acute resolving to chronic persistent inflammation. Trends Immunol 2001; 22:199-204; PMID:11274925; http://dx.doi.org/10.1016/S1471-4906(01)01863-4
10. R.Kalluri, M.Zeisberg. Fibroblasts in cancer. Nat Rev Cancer 2006; 6:392-401; PMID:16572188; http://dx.doi.org/10.1038/nrc1877
11. M.R.Nazareth, L.Broderick, M.R.Simpson-Abelson, R.J.Kelleher, Jr., S.J.Yokota, R.B.Bankert. Characterization of human lung tumor-associated fibroblasts and their ability to modulate the activation of tumor-associated T cells. J Immunol 2007; 178:5552-62; PMID:17442937; http://dx.doi.org/10.4049/jimmunol.178.9.5552
12. M.E.Keir, M.J.Butte, G.J.Freeman, A.H.Sharpe. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol 2008; 26:677-704; PMID:18173375; http://dx.doi.org/10.1146/annurev.immunol.26.021607.090331
13. J.M.Chemnitz, R.V.Parry, K.E.Nichols, C.H.June, J.L.Riley. SHP-1 and SHP-2 associate with immunoreceptor tyrosine-based switch motif of programmed death 1 upon primary human T cell stimulation, but only receptor ligation prevents T cell activation. J Immunol 2004; 173:945-54; PMID:15240681; http://dx.doi.org/10.4049/jimmunol.173.2.945
14. E.Gianchecchi, D.V.Delfino, A.Fierabracci. Recent insights into the role of the PD-1/PD-L1 pathway in immunological tolerance and autoimmunity. Autoimmun Rev 2013; 12:1091-100; PMID:23792703; http://dx.doi.org/10.1016/j.autrev.2013.05.003
15. D.M.Pardoll. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer 2012; 12:252-64; PMID:22437870; http://dx.doi.org/10.1038/nrc3239
16. O.Hamid, C.Robert, A.Daud, F.S.Hodi, W.J.Hwu, R.Kefford, J.D.Wolchok, P.Hersey, R.W.Joseph, J.S.Weber et al. Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma. N Engl J Med 2013; 369:134-44; PMID:23724846; http://dx.doi.org/10.1056/NEJMoa1305133
17. C.Robert, B.Karaszewska, J.Schachter, P.Rutkowski, A.Mackiewicz, D.Stroiakovski, M.Lichinitser, R.Dummer, F.Grange, L.Mortier et al. Improved overall survival in melanoma with combined dabrafenib and trametinib. N Engl J Med 2015; 372:30-9; PMID:25399551; http://dx.doi.org/10.1056/NEJMoa1412690
18. S.L.Topalian, F.S.Hodi, J.R.Brahmer, S.N.Gettinger, D.C.Smith, D.F.McDermott, J.D.Powderly, R.D.Carvajal, J.A.Sosman, M.B.Atkins et al. Safety, activity, and immune correlates of anti-PD-1 antibody in cancer. N Engl J Med 2012; 366:2443-54; PMID:22658127; http://dx.doi.org/10.1056/NEJMoa1200690
19. P.C.Tumeh, C.L.Harview, J.H.Yearley, I.P.Shintaku, E.J.Taylor, L.Robert, B.Chmielowski, M.Spasic, G.Henry, V.Ciobanu et al. PD-1 blockade induces responses by inhibiting adaptive immune resistance. Nature 2014; 515:568-71; PMID:25428505; http://dx.doi.org/10.1038/nature13954
20. R.S.Herbst, J.C.Soria, M.Kowanetz, G.D.Fine, O.Hamid, M.S.Gordon, J.A.Sosman, D.F.McDermott, J.D.Powderly, S.N.Gettinger et al. Predictive correlates of response to the anti-PD-L1 antibody MPDL3280A in cancer patients. Nature 2014; 515:563-7; PMID:25428504; http://dx.doi.org/10.1038/nature14011
21. T.Powles, J.P.Eder, G.D.Fine, F.S.Braiteh, Y.Loriot, C.Cruz, J.Bellmunt, H.A.Burris, D.P.Petrylak, S.L.Teng et al. MPDL3280A (anti-PD-L1) treatment leads to clinical activity in metastatic bladder cancer. Nature 2014; 515:558-62; PMID:25428503; http://dx.doi.org/10.1038/nature13904
22. J.M.Taube, A.Klein, J.R.Brahmer, H.Xu, X.Pan, J.H.Kim, L.Chen, D.M.Pardoll, S.L.Topalian, R.A.Anders. Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy. Clin Cancer Res 2014; 20:5064-74; PMID:24714771; http://dx.doi.org/10.1158/1078-0432.CCR-13-3271
23. M.J.Eppihimer, J.Gunn, G.J.Freeman, E.A.Greenfield, T.Chernova, J.Erickson, J.P.Leonard. Expression and regulation of the PD-L1 immunoinhibitory molecule on microvascular endothelial cells. Microcirculation 2002; 9:133-45; PMID:11932780; http://dx.doi.org/10.1080/713774061
24. E.F.Tewalt, J.N.Cohen, S.J.Rouhani, C.J.Guidi, H.Qiao, S.P.Fahl, M.R.Conaway, T.P.Bender, K.S.Tung, A.T.Vella et al. Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells. Blood 2012; 120:4772-82; PMID:22993390; http://dx.doi.org/10.1182/blood-2012-04-427013
25. M.E.Keir, S.C.Liang, I.Guleria, Y.E.Latchman, A.Qipo, L.A.Albacker, M.Koulmanda, G.J.Freeman, M.H.Sayegh, A.H.Sharpe. Tissue expression of PD-L1 mediates peripheral T cell tolerance. J Exp Med 2006; 203:883-95; PMID:16606670; http://dx.doi.org/10.1084/jem.20051776
26. P.Youngnak-Piboonratanakit, F.Tsushima, N.Otsuki, H.Igarashi, U.Machida, H.Iwai, Y.Takahashi, K.Omura, H.Yokozeki, M.Azuma. The expression of B7-H1 on keratinocytes in chronic inflammatory mucocutaneous disease and its regulatory role. Immunol Lett 2004; 94:215-22; PMID:15275969; http://dx.doi.org/10.1016/j.imlet.2004.05.007
27. Y.Latchman, C.R.Wood, T.Chernova, D.Chaudhary, M.Borde, I.Chernova, Y.Iwai, A.J.Long, J.A.Brown, R.Nunes et al. PD-L2 is a second ligand for PD-1 and inhibits T cell activation. Nat Immunol 2001; 2:261-8; PMID:11224527; http://dx.doi.org/10.1038/85330
28. E.N.Rozali, S.V.Hato, B.W.Robinson, R.A.Lake, W.J.Lesterhuis. Programmed death ligand 2 in cancer-induced immune suppression. Clin Dev Immunol 2012; 2012:656340; PMID:22611421; http://dx.doi.org/10.1155/2012/656340
29. P.Youngnak, Y.Kozono, H.Kozono, H.Iwai, N.Otsuki, H.Jin, K.Omura, H.Yagita, D.M.Pardoll, L.Chen et al. Differential binding properties of B7-H1 and B7-DC to programmed death-1. Biochem Biophys Res Commun 2003; 307:672-7; PMID:12893276; http://dx.doi.org/10.1016/S0006-291X(03)01257-9
30. A.Augello, R.Tasso, S.M.Negrini, A.Amateis, F.Indiveri, R.Cancedda, G.Pennesi. Bone marrow mesenchymal progenitor cells inhibit lymphocyte proliferation by activation of the programmed death 1 pathway. Eur J Immunol 2005; 35:1482-90; PMID:15827960; http://dx.doi.org/10.1002/eji.200425405
31. S.K.Lee, S.H.Seo, B.S.Kim, C.D.Kim, J.H.Lee, J.S.Kang, P.J.Maeng, J.S.Lim. IFN-gamma regulates the expression of B7-H1 in dermal fibroblast cells. J Dermatol Sci 2005; 40:95-103; PMID:16085391; http://dx.doi.org/10.1016/j.jdermsci.2005.06.008
32. I.V.Pinchuk, J.I.Saada, E.J.Beswick, G.Boya, S.M.Qiu, R.C.Mifflin, G.S.Raju, V.E.Reyes, D.W.Powell. PD-1 ligand expression by human colonic myofibroblasts/fibroblasts regulates CD4+ T-cell activity. Gastroenterol 2008; 135:1228-37, 1237; PMID:18760278; http://dx.doi.org/10.1053/j.gastro.2008.07.016
33. X.Wang, A.K.Marr, T.Breitkopf, G.Leung, J.Hao, E.Wang, N.Kwong, N.Akhoundsadegh, L.Chen, A.Mui et al. Hair follicle mesenchyme-associated PD-L1 regulates T-cell activation induced apoptosis: a potential mechanism of immune privilege. J Invest Dermatol 2014; 134:736-45; PMID:24005055; http://dx.doi.org/10.1038/jid.2013.368
34. J.Stagg, S.Pommey, N.Eliopoulos, J.Galipeau. Interferon-gamma-stimulated marrow stromal cells: a new type of nonhematopoietic antigen-presenting cell. Blood 2006; 107:2570-7; PMID:16293599; http://dx.doi.org/10.1182/blood-2005-07-2793
35. A.V.de Andrade, J.Riewaldt, R.Wehner, M.Schmitz, M.Odendahl, M.Bornhauser, T.Tonn. Gamma irradiation preserves immunosuppressive potential and inhibits clonogenic capacity of human bone marrow-derived mesenchymal stromal cells. J Cell Mol Med 2014; 18:1184-93; PMID:24655362; http://dx.doi.org/10.1111/jcmm.12264
36. N.Fekete, A.Erle, E.M.Amann, D.Furst, M.T.Rojewski, A.Langonne, L.Sensebe, H.Schrezenmeier, G.Schmidtke-Schrezenmeier. Effect of High-Dose Irradiation on Human Bone-Marrow-Derived Mesenchymal Stromal Cells. Tissue Eng Part C Methods 2015; 21:212–22; PMID:24918644; http://dx.doi.org/10.1089/ten.TEC.2013.0766
37. M.Ghiotto, L.Gauthier, N.Serriari, S.Pastor, A.Truneh, J.A.Nunes, D.Olive. PD-L1 and PD-L2 differ in their molecular mechanisms of interaction with PD-1. Int Immunol 2010; 22:651-60; PMID:20587542; http://dx.doi.org/10.1093/intimm/dxq049
38. J.M.Lemons, X.J.Feng, B.D.Bennett, A.Legesse-Miller, E.L.Johnson, I.Raitman, E.A.Pollina, H.A.Rabitz, J.D.Rabinowitz, H.A.Coller. Quiescent fibroblasts exhibit high metabolic activity. PLoS Biol 2010; 8:e1000514; PMID:21049082; http://dx.doi.org/10.1371/journal.pbio.1000514
39. A.Papadopoulou, D.Kletsas. Human lung fibroblasts prematurely senescent after exposure to ionizing radiation enhance the growth of malignant lung epithelial cells in vitro and in vivo. Int J Oncol 2011; 39:989-99; PMID:21814715; http://dx.doi.org/10.3892/ijo.2011.1132
40. F.Debacq-Chainiaux, J.D.Erusalimsky, J.Campisi, O.Toussaint. Protocols to detect senescence-associated β-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4:1798-806; PMID:20010931; http://dx.doi.org/10.1038/nprot.2009.191
41. R.Khokha, A.Murthy, A.Weiss. Metalloproteinases and their natural inhibitors in inflammation and immunity. Nat Rev Immunol 2013; 13:649-65; PMID:23969736; http://dx.doi.org/10.1038/nri3499
42. A.Merdad, S.Karim, H.J.Schulten, A.Dallol, A.Buhmeida, F.Al-Thubaity, M.A.Gari, A.G.Chaudhary, A.M.Abuzenadah, M.H.Al-Qahtani. Expression of matrix metalloproteinases (MMPs) in primary human breast cancer: MMP-9 as a potential biomarker for cancer invasion and metastasis. Anticancer Res 2014; 34:1355-66; PMID:24596383
43. M.Toriseva, M.Laato, O.Carpen, S.T.Ruohonen, E.Savontaus, M.Inada, S.M.Krane, V.M.Kahari. MMP-13 regulates growth of wound granulation tissue and modulates gene expression signatures involved in inflammation, proteolysis, and cell viability. PLoS One 2012; 7:e42596; PMID:22880047; http://dx.doi.org/10.1371/journal.pone.0042596
44. S.Dai, R.Jia, X.Zhang, Q.Fang, L.Huang. The PD-1/PD-Ls pathway and autoimmune diseases. Cell Immunol 2014; 290:72-9; PMID:24908630; http://dx.doi.org/10.1016/j.cellimm.2014.05.006
45. Y.Z.Gu, Q.Xue, Y.J.Chen, G.H.Yu, M.D.Qing, Y.Shen, M.Y.Wang, Q.Shi, X.G.Zhang. Different roles of PD-L1 and FasL in immunomodulation mediated by human placenta-derived mesenchymal stem cells. Hum Immunol 2013; 74:267-76; PMID:23261407; http://dx.doi.org/10.1016/j.humimm.2012.12.011
46. K.English, F.P.Barry, B.P.Mahon. Murine mesenchymal stem cells suppress dendritic cell migration, maturation and antigen presentation. Immunol Lett 2008; 115:50-8; PMID:18022251; http://dx.doi.org/10.1016/j.imlet.2007.10.002
47. C.J.Chang, M.L.Yen, Y.C.Chen, C.C.Chien, H.I.Huang, C.H.Bai, B.L.Yen. Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma. Stem Cells 2006; 24:2466-77; PMID:17071860; http://dx.doi.org/10.1634/stemcells.2006-0071
48. B.Schreiner, M.Mitsdoerffer, B.C.Kieseier, L.Chen, H.P.Hartung, M.Weller, H.Wiendl. Interferon-β enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis. J Neuroimmunol 2004; 155:172-82; PMID:15342209; http://dx.doi.org/10.1016/j.jneuroim.2004.06.013
49. E.A.Akbay, S.Koyama, J.Carretero, A.Altabef, J.H.Tchaicha, C.L.Christensen, O.R.Mikse, A.D.Cherniack, E.M.Beauchamp, T.J.Pugh et al. Activation of the PD-1 pathway contributes to immune escape in EGFR-driven lung tumors. Cancer Discov 2013; 3:1355-63; PMID:24078774; http://dx.doi.org/10.1158/2159-8290.CD-13-0310
50. W.Xu, H.Jiang, J.Gao, Y.Zhao. The upregulation of immune checkpoint ligand PD-L1 in tumour microenvironment. Scand J Immunol 2014; 80:71-2; PMID:24684652; http://dx.doi.org/10.1111/sji.12177
51. N.Rodig, T.Ryan, J.A.Allen, H.Pang, N.Grabie, T.Chernova, E.A.Greenfield, S.C.Liang, A.H.Sharpe, A.H.Lichtman et al. Endothelial expression of PD-L1 and PD-L2 down-regulates CD8+ T cell activation and cytolysis. Eur J Immunol 2003; 33:3117-26; PMID:14579280; http://dx.doi.org/10.1002/eji.200324270
52. L.A.Stanciu, C.M.Bellettato, V.Laza-Stanca, A.J.Coyle, A.Papi, S.L.Johnston. Expression of programmed death-1 ligand (PD-L) 1, PD-L2, B7-H3, and inducible costimulator ligand on human respiratory tract epithelial cells and regulation by respiratory syncytial virus and type 1 and 2 cytokines. J Infect Dis 2006; 193:404-12; PMID:16388488; http://dx.doi.org/10.1086/499275
53. M.Muhlbauer, M.Fleck, C.Schutz, T.Weiss, M.Froh, C.Blank, J.Scholmerich, C.Hellerbrand. PD-L1 is induced in hepatocytes by viral infection and by interferon-α and -gamma and mediates T cell apoptosis. J Hepatol 2006; 45:520-8; PMID:16876901; http://dx.doi.org/10.1016/j.jhep.2006.05.007
54. A.L.Kinter, E.J.Godbout, J.P.McNally, I.Sereti, G.A.Roby, M.A.O'Shea, A.S.Fauci. The common gamma-chain cytokines IL-2, IL-7, IL-15, and IL-21 induce the expression of programmed death-1 and its ligands. J Immunol 2008; 181:6738-46; PMID:18981091; http://dx.doi.org/10.4049/jimmunol.181.10.6738
55. W.J.Lesterhuis, H.Steer, R.A.Lake. PD-L2 is predominantly expressed by Th2 cells. Mol Immunol 2011; 49:1-3; PMID:22000002; http://dx.doi.org/10.1016/j.molimm.2011.09.014
56. T.J.Curiel, S.Wei, H.Dong, X.Alvarez, P.Cheng, P.Mottram, R.Krzysiek, K.L.Knutson, B.Daniel, M.C.Zimmermann et al. Blockade of B7-H1 improves myeloid dendritic cell-mediated antitumor immunity. Nat Med 2003; 9:562-7; PMID:12704383; http://dx.doi.org/10.1038/nm863
57. F.Shi, M.Shi, Z.Zeng, R.Z.Qi, Z.W.Liu, J.Y.Zhang, Y.P.Yang, P.Tien, F.S.Wang. PD-1 and PD-L1 upregulation promotes CD8(+) T-cell apoptosis and postoperative recurrence in hepatocellular carcinoma patients. Int J Cancer 2011; 128:887-96; PMID:20473887; http://dx.doi.org/10.1002/ijc.25397
58. J.R.Benson, L.M.Wakefield, M.Baum, A.A.Colletta. Synthesis and secretion of transforming growth factor β isoforms by primary cultures of human breast tumour fibroblasts in vitro and their modulation by tamoxifen. Br J Cancer 1996; 74:352-8; PMID:8695348; http://dx.doi.org/10.1038/bjc.1996.365
59. K.Ina, K.Kusugami, Y.Kawano, T.Nishiwaki, Z.Wen, A.Musso, G.A.West, M.Ohta, H.Goto, C.Fiocchi. Intestinal fibroblast-derived IL-10 increases survival of mucosal T cells by inhibiting growth factor deprivation- and Fas-mediated apoptosis. J Immunol 2005; 175:2000-9; PMID:16034145; http://dx.doi.org/10.4049/jimmunol.175.3.2000
60. G.Pang, L.Couch, R.Batey, R.Clancy, A.Cripps. GM-CSF, IL-1 α, IL-1 β, IL-6, IL-8, IL-10, ICAM-1 and VCAM-1 gene expression and cytokine production in human duodenal fibroblasts stimulated with lipopolysaccharide, IL-1 α and TNF-α. Clin Exp Immunol 1994; 96:437-43; PMID:8004813; http://dx.doi.org/10.1111/j.1365-2249.1994.tb06048.x
61. I.Rasmusson, O.Ringden, B.Sundberg, B.K.Le. Mesenchymal stem cells inhibit lymphocyte proliferation by mitogens and alloantigens by different mechanisms. Exp Cell Res 2005; 305:33-41; PMID:15777785; http://dx.doi.org/10.1016/j.yexcr.2004.12.013
62. K.Sarkhosh, E.E.Tredget, A.Karami, H.Uludag, T.Iwashina, R.T.Kilani, A.Ghahary. Immune cell proliferation is suppressed by the interferon-gamma-induced indoleamine 2,3-dioxygenase expression of fibroblasts populated in collagen gel (FPCG). J Cell Biochem 2003; 90:206-17; PMID:12938169; http://dx.doi.org/10.1002/jcb.10593
63. K.Kessenbrock, V.Plaks, Z.Werb. Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 2010; 141:52-67; PMID:20371345; http://dx.doi.org/10.1016/j.cell.2010.03.015
64. M.J.Toriseva, R.Ala-aho, J.Karvinen, A.H.Baker, V.S.Marjomaki, J.Heino, V.M.Kahari. Collagenase-3 (MMP-13) enhances remodeling of three-dimensional collagen and promotes survival of human skin fibroblasts. J Invest Dermatol 2007; 127:49-59; PMID:16917496; http://dx.doi.org/10.1038/sj.jid.5700500
65. Y.Chen, Q.Wang, B.Shi, P.Xu, Z.Hu, L.Bai, X.Zhang. Development of a sandwich ELISA for evaluating soluble PD-L1 (CD274) in human sera of different ages as well as supernatants of PD-L1+ cell lines. Cytokine 2011; 56:231-8; PMID:21733718; http://dx.doi.org/10.1016/j.cyto.2011.06.004
66. X.Frigola, B.A.Inman, C.M.Lohse, C.J.Krco, J.C.Cheville, R.H.Thompson, B.Leibovich, M.L.Blute, H.Dong, E.D.Kwon. Identification of a soluble form of B7-H1 that retains immunosuppressive activity and is associated with aggressive renal cell carcinoma. Clin Cancer Res 2011; 17:1915-23; PMID:21355078; http://dx.doi.org/10.1158/1078-0432.CCR-10-0250
67. X.H.He, Y.Liu, L.H.Xu, Y.Y.Zeng. Cloning and identification of two novel splice variants of human PD-L2. Acta Biochim Biophys Sin (Shanghai) 2004; 36:284-9; PMID:15253154; http://dx.doi.org/10.1093/abbs/36.4.284
68. G.Murphy, A.Murthy, R.Khokha. Clipping, shedding and RIPping keep immunity on cue. Trends Immunol 2008; 29:75-82; PMID:18182322; http://dx.doi.org/10.1016/j.it.2007.10.009
69. G.A.McQuibban, J.H.Gong, E.M.Tam, C.A.McCulloch, I.Clark-Lewis, C.M.Overall. Inflammation dampened by gelatinase A cleavage of monocyte chemoattractant protein-3. Science 2000; 289:1202-6; PMID:10947989; http://dx.doi.org/10.1126/science.289.5482.1202
70. P.E.Van den Steen, A.Wuyts, S.J.Husson, P.Proost, D.J.Van, G.Opdenakker. Gelatinase B/MMP-9 and neutrophil collagenase/MMP-8 process the chemokines human GCP-2/CXCL6, ENA-78/CXCL5 and mouse GCP-2/LIX and modulate their physiological activities. Eur J Biochem 2003; 270:3739-49; PMID:12950257; http://dx.doi.org/10.1046/j.1432-1033.2003.03760.x
71. P.E.Van den Steen, S.J.Husson, P.Proost, D.J.Van, G.Opdenakker. Carboxyterminal cleavage of the chemokines MIG and IP-10 by gelatinase B and neutrophil collagenase. Biochem Biophys Res Commun 2003; 310:889-96; PMID:14550288; http://dx.doi.org/10.1016/j.bbrc.2003.09.098
72. R.A.Black, C.T.Rauch, C.J.Kozlosky, J.J.Peschon, J.L.Slack, M.F.Wolfson, B.J.Castner, K.L.Stocking, P.Reddy, S.Srinivasan et al. A metalloproteinase disintegrin that releases tumour-necrosis factor-α from cells. Nature 1997; 385:729-33; PMID:9034190; http://dx.doi.org/10.1038/385729a0
73. G.Weskamp, J.W.Ford, J.Sturgill, S.Martin, A.J.Docherty, S.Swendeman, N.Broadway, D.Hartmann, P.Saftig, S.Umland et al. ADAM10 is a principal ‘sheddase’ of the low-affinity immunoglobulin E receptor CD23. Nat Immunol 2006; 7:1293-8; PMID:17072319; http://dx.doi.org/10.1038/ni1399
74. E.C.Logue, S.Bakkour, M.M.Murphy, H.Nolla, W.C.Sha. ICOS-induced B7h shedding on B cells is inhibited by TLR7/8 and TLR9. J Immunol 2006; 177:2356-64; PMID:16887997; http://dx.doi.org/10.4049/jimmunol.177.4.2356
75. J.Sun, L.J.Chen, G.B.Zhang, J.T.Jiang, M.Zhu, Y.Tan, H.T.Wang, B.F.Lu, X.G.Zhang. Clinical significance and regulation of the costimulatory molecule B7-H3 in human colorectal carcinoma. Cancer Immunol Immunother 2010; 59:1163-71; PMID:20333377; http://dx.doi.org/10.1007/s00262-010-0841-1
76. G.Zhang, J.Hou, J.Shi, G.Yu, B.Lu, X.Zhang. Soluble CD276 (B7-H3) is released from monocytes, dendritic cells and activated T cells and is detectable in normal human serum. Immunology 2008; 123:538-46; PMID:18194267; http://dx.doi.org/10.1111/j.1365-2567.2007.02723.x
77. E.Schlecker, N.Fiegler, A.Arnold, P.Altevogt, S.Rose-John, G.Moldenhauer, A.Sucker, A.Paschen, E.P.von Strandmann, S.Textor et al. Metalloprotease-mediated tumor cell shedding of B7-H6, the ligand of the natural killer cell-activating receptor NKp30. Cancer Res 2014; 74:3429-40; PMID:24780758; http://dx.doi.org/10.1158/0008-5472.CAN-13-3017
78. J.J.Park, R.Omiya, Y.Matsumura, Y.Sakoda, A.Kuramasu, M.M.Augustine, S.Yao, F.Tsushima, H.Narazaki, S.Anand et al. B7-H1/CD80 interaction is required for the induction and maintenance of peripheral T-cell tolerance. Blood 2010; 116:1291-8; PMID:20472828; http://dx.doi.org/10.1182/blood-2010-01-265975
79. G.J.Freeman, A.J.Long, Y.Iwai, K.Bourque, T.Chernova, H.Nishimura, L.J.Fitz, N.Malenkovich, T.Okazaki, M.C.Byrne et al. Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192:1027-34; PMID:11015443; http://dx.doi.org/10.1084/jem.192.7.1027
80. H.Nishimura, T.Okazaki, Y.Tanaka, K.Nakatani, M.Hara, A.Matsumori, S.Sasayama, A.Mizoguchi, H.Hiai, N.Minato et al. Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291:319-22; PMID:11209085; http://dx.doi.org/10.1126/science.291.5502.319
81. Y.Jiang, Y.Li, B.Zhu. T-cell exhaustion in the tumor microenvironment. Cell Death Dis 2015; 6:e1792; PMID:26086965; http://dx.doi.org/10.1038/cddis.2015.162
82. J.M.Freije, I.Diez-Itza, M.Balbin, L.M.Sanchez, R.Blasco, J.Tolivia, C.Lopez-Otin. Molecular cloning and expression of collagenase-3, a novel human matrix metalloproteinase produced by breast carcinomas. J Biol Chem 1994; 269:16766-73; PMID:8207000
83. N.J.Heredia, P.Belgrader, S.Wang, R.Koehler, J.Regan, A.M.Cosman, S.Saxonov, B.Hindson, S.C.Tanner, A.S.Brown et al. Droplet Digital PCR quantitation of HER2 expression in FFPE breast cancer samples. Methods 2013; 59:S20-3; PMID:23036330; http://dx.doi.org/10.1016/j.ymeth.2012.09.012
84. B.J.Hindson, K.D.Ness, D.A.Masquelier, P.Belgrader, N.J.Heredia, A.J.Makarewicz, I.J.Bright, M.Y.Lucero, A.L.Hiddessen, T.C.Legler et al. High-throughput droplet digital PCR system for absolute quantitation of DNA copy number. Anal Chem 2011; 83:8604-10; PMID:22035192; http://dx.doi.org/10.1021/ac202028g